Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Double Blind Controlled Trial of an Extensively Hydrolyzed Formula With a Probiotic vs. an Extensively Hydrolyzed Formula Without a Probiotic

This study has been completed.
Information provided by:
Mead Johnson Nutrition Identifier:
First received: August 12, 2010
Last updated: NA
Last verified: August 2010
History: No changes posted
The purpose of this study is to confirm the hypoallergenicity of an extensively hydrolyzed formula with an added probiotic in children with documented milk allergy.

Condition Intervention
Other: Extensively Hydrolyzed Formula with a Probiotic
Other: Extensively Hydrolyzed Formula without a Probiotic

Study Type: Interventional

Further study details as provided by Mead Johnson Nutrition:

Study Start Date: January 2003
Study Completion Date: November 2004
Primary Completion Date: November 2004 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Extensively Hydrolyzed Formula with a Probiotic
Extensively Hydrolyzed Formula with a Probiotic
Other: Extensively Hydrolyzed Formula with a Probiotic
Placebo Comparator: Extensively Hydrolyzed Formula without a Probiotic Other: Extensively Hydrolyzed Formula without a Probiotic


Ages Eligible for Study:   up to 14 Years   (Child)

Inclusion Criteria:

  • ≤14 years of age
  • Essentially asymptomatic for a minimum of 7 days pre-challenge.
  • Successful previous consumption of Extensively Hydrolyzed Formula within 1 week of study enrollment
  • Medically documented allergy to cow's milk

Exclusion Criteria:

  • Presence of underlying systemic disease or other illness
  • Used Beta-blockers within 12-24 hours of challenges
  • Use of short-acting antihistamines within 3 days
  • Use of medium-acting antihistamines within 7 days
  • Use of long-acting antihistamines within 6 weeks
  • Use of oral steroid medication within 3 weeks
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01181297

Dept. of Paediatrics, Azienda Ospedaliera di Padova
Padova, Veneto, Italy, 35128
Wilhelmina Children's Hospital
Utrecht, Netherlands, 3508
Sponsors and Collaborators
Mead Johnson Nutrition
  More Information

Publications automatically indexed to this study by Identifier (NCT Number): Identifier: NCT01181297     History of Changes
Other Study ID Numbers: 3369-2
Study First Received: August 12, 2010
Last Updated: August 12, 2010

Keywords provided by Mead Johnson Nutrition:
Confirmed milk allergy processed this record on May 24, 2017